Characteristic | PET/MRI for initial staging | PET/CT due to BCR |
n | 47 | 57 |
Age (y) | 64.2 ± 6.1 (44–74) | 70.5 ± 6.7 (58–89) |
Prostate-specific antigen (ng/mL) | 10.4 ± 8.4 (3.3–50.4) | 35.7 ± 172.2 (0.2–1.170) |
Injected dose (MBq) | 155.4 ± 30.7 (91.4–236.4) | 145.8 ± 14.8 (111–199.8) |
Uptake time (min) | 49.9 ± 5.3 (41–69) | 61.4 ± 13.6 (44–90) |
Treatment before PET/CT | Not applicable | Prostatectomy, 41; radiotherapy, 32; brachytherapy, 6; hormonal therapy, 36; chemotherapy, 3; 223Ra, 1 |
Continuous data are expressed as mean ± SD, followed by range in parentheses.